Egyptian International Pharmaceutical Industries Company
Egyptian International Pharmaceutical Industries Company, commonly known as EIPICO, is a leading player in the pharmaceutical industry, headquartered in Egypt. Established in 1980, EIPICO has made significant strides in the production of high-quality generic medications, catering to both local and international markets. With a strong operational presence across the Middle East and North Africa, EIPICO focuses on a diverse range of therapeutic areas, including antibiotics, cardiovascular drugs, and anti-diabetics. The company is renowned for its commitment to innovation and quality, utilising advanced manufacturing techniques to ensure the efficacy and safety of its products. EIPICO's dedication to excellence has positioned it as a market leader, achieving notable milestones in production capacity and regulatory compliance. With a robust portfolio of over 200 products, EIPICO continues to contribute significantly to the healthcare landscape in Egypt and beyond.
DitchCarbon Score
How does Egyptian International Pharmaceutical Industries Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Egyptian International Pharmaceutical Industries Company's score of 22 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Egyptian International Pharmaceutical Industries Company's reported carbon emissions
Egyptian International Pharmaceutical Industries Company (EIPICO), headquartered in Egypt, currently does not have publicly available data on its carbon emissions. As such, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of specific emissions data, it is important to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate commitments. This often includes setting science-based targets for emissions reductions and implementing strategies to enhance energy efficiency and reduce waste. EIPICO's commitment to addressing climate change may align with broader industry trends, but without specific data or targets, it is challenging to assess their current impact or future commitments in this area.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Egyptian International Pharmaceutical Industries Company is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
